Literature DB >> 25000150

Measuring the value of mortality risk reductions in Turkey.

Cem Tekeşin1, Shihomi Ara2.   

Abstract

The willingness to pay (WTP) for mortality risk reduction from four causes (lung cancer, other type of cancer, respiratory disease, traffic accident) are estimated using random parameter logit model with data from choice experiment for three regions in Turkey. The value of statistical life (VSL) estimated for Afsin-Elbistan, Kutahya-Tavsanli, Ankara and the pooled case are found as 0.56, 0.35, 0.46 and 0.49 million Purchasing Power Parity (PPP) adjusted 2012 US dollars (USD). Different types of risk cause different VSL estimates and we found the lung cancer premium of 213% against traffic accident. The effects of one-year-delayed provision of risk-reduction service are the reduction of WTP by 482 TL ($318 in PPP adjusted USD) per person on average, and the disutility from status-quo (zero risk reduction) against alternative is found to be 891 TL ($589 in PPP adjusted USD) per person on average. Senior discounts of VSL are partially determined by status-quo preference and the amount of discount decreases once the status-quo bias is removed. The peak VSL is found to be for the age group 30-39 and the average VSL for the age group is 0.8 million PPP adjusted USD). Turkey's compliance to European Union (EU) air quality standard will cause welfare gains of total 373 million PPP adjusted USD for our study areas in terms of reduced number of premature mortality.

Entities:  

Mesh:

Year:  2014        PMID: 25000150      PMCID: PMC4113852          DOI: 10.3390/ijerph110706890

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  3 in total

1.  Value of statistical life and cause of accident: a choice experiment.

Authors:  Fredrik Carlsson; Dinky Daruvala; Henrik Jaldell
Journal:  Risk Anal       Date:  2010-04-08       Impact factor: 4.000

2.  Willingness to pay for reducing fatal risk by improving air quality: a contingent valuation study in Chongqing, China.

Authors:  Hong Wang; John Mullahy
Journal:  Sci Total Environ       Date:  2006-04-03       Impact factor: 7.963

3.  Assessing whether there is a cancer premium for the value of a statistical life.

Authors:  W Kip Viscusi; Joel Huber; Jason Bell
Journal:  Health Econ       Date:  2013-03-21       Impact factor: 3.046

  3 in total
  5 in total

1.  A pharmacoeconomic approach to assessing the costs and benefits of air quality interventions that improve health: a case study.

Authors:  James Lomas; Laetitia Schmitt; Sally Jones; Maureen McGeorge; Elizabeth Bates; Mike Holland; Duncan Cooper; Richard Crowther; Mike Ashmore; David Rojas-Rueda; Helen Weatherly; Gerry Richardson; Laura Bojke
Journal:  BMJ Open       Date:  2016-06-21       Impact factor: 2.692

Review 2.  Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics.

Authors:  Liz Morrell; Sarah Wordsworth; Sian Rees; Richard Barker
Journal:  Pharmacoeconomics       Date:  2017-08       Impact factor: 4.981

3.  Effect of Income Heterogeneity on Valuation of Mortality Risk in Taiwan: An Application of Unconditional Quantile Regression Method.

Authors:  Je-Liang Liou
Journal:  Int J Environ Res Public Health       Date:  2019-05-09       Impact factor: 3.390

4.  The Monetary Valuation of Lifetime Health Improvement and Life Expectancy Gains in Turkey.

Authors:  Shihomi Ara; Cem Tekeşin
Journal:  Int J Environ Res Public Health       Date:  2017-09-29       Impact factor: 3.390

5.  Cost- Effectiveness of Mammography Screening Program in a Resource-Limited Post-Soviet Country of Kazakhstan.

Authors:  Islam Salikhanov; Byron Crape; Peter Howie
Journal:  Asian Pac J Cancer Prev       Date:  2019-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.